Alpha Crest Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History

Alpha Crest Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$13.42 - $20.28 $713,286 - $1.08 Million	-53,151 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.77 - $13.81 $14,860 - $21,005	1,521 Added 2.95%	53,151 $698,000
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $309,535 - $399,208	33,212 Added 180.32%	51,630 $499,000
Q2 2020 Aug 12, 2020	SELL	$9.66 - $12.02 $171,948 - $213,956	-17,800 Reduced 49.15%	18,418 $211,000
Q1 2020 May 13, 2020	BUY	$7.5 - $16.8 $99,802 - $223,557	13,307 Added 58.08%	36,218 $375,000
Q4 2019 Feb 12, 2020	SELL	$12.38 - $17.47 $358,883 - $506,437	-28,989 Reduced 55.86%	22,911 $376,000
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $636,813 - $819,501	51,900 New	51,900 $689,000
Q2 2019 Aug 12, 2019	SELL	$13.37 - $18.85 $346,283 - $488,215	-25,900 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$17.59 - $31.05 $455,581 - $804,195	25,900 New	25,900 $477,000

152

43.3M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $245M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.